NNNN
HEALTHCAREAnbio Biotechnology - Class A
$26.60-2.60 (-8.90%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NNNN Today?
No stock-specific AI insight has been generated for NNNN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.40$55.65
$26.60
Fundamentals
Market Cap$1.2B
P/E Ratio177.3
EPS$0.15
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.7%
Debt / Equity—
Trading
Volume47K
Avg Volume (10D)—
Shares Outstanding43.9M
NNNN News
20 articles- Discovering US Market's Undiscovered Gems in May 2026Yahoo Finance·May 7, 2026
- Undiscovered Gems in the US Market for May 2026Yahoo Finance·May 7, 2026
- Undiscovered Gems In The US Market Featuring 3 Promising Small CapsYahoo Finance·May 6, 2026
- 3 Undiscovered Gems In The US Market To WatchYahoo Finance·Apr 29, 2026
- Unveiling 3 Undiscovered Gems in the US MarketYahoo Finance·Apr 28, 2026
- US Undiscovered Gems To Explore In April 2026Yahoo Finance·Apr 28, 2026
- Discovering US Undiscovered Gems This April 2026Yahoo Finance·Apr 24, 2026
- Undiscovered Gems US Market April 2026Yahoo Finance·Apr 24, 2026
- US Market's Undiscovered Gems 3 Promising Small CapsYahoo Finance·Apr 20, 2026
- US Market's Hidden Gems: 3 Promising Small CapsYahoo Finance·Apr 20, 2026
- Discovering 3 US Small Cap Gems with Promising PotentialYahoo Finance·Apr 16, 2026
- US Undiscovered Gems to Watch in April 2026Yahoo Finance·Apr 13, 2026
- Discovering US Undiscovered Gems with Potential In April 2026Yahoo Finance·Apr 10, 2026
- Discovering US Undiscovered Gems In April 2026Yahoo Finance·Apr 9, 2026
- Discovering US Undiscovered Gems for April 2026Yahoo Finance·Apr 9, 2026
- Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare ForumYahoo Finance·Mar 17, 2026
- Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?Yahoo Finance·Jan 1, 2026
- Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025Yahoo Finance·Oct 9, 2025
- Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR SystemYahoo Finance·Aug 9, 2025
- Anbio Biotechnology (NASDAQ:NNNN) Has A ROE Of 14%Yahoo Finance·Jul 13, 2025
All 20 articles loaded
Price Data
Open$31.00
Previous Close$29.20
Day High$32.70
Day Low$29.00
52 Week High$55.65
52 Week Low$6.40
52-Week Range
$6.40$55.65
$26.60
Fundamentals
Market Cap$1.2B
P/E Ratio177.3
EPS$0.15
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.7%
Debt / Equity—
Trading
Volume47K
Avg Volume (10D)—
Shares Outstanding43.9M
About Anbio Biotechnology - Class A
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—